AAAAAA

   
Results: 1-18 |
Results: 18
LYMPHOMA
Authors: MOHAR A SOBREVILLACALVO P VELASQUEZ WS
Citation: A. Mohar et al., LYMPHOMA, Revista de Investigacion Clinica, 49, 1997, pp. 56-63
RETREATMENTS WITH RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) HAVE SIGNIFICANTEFFICACY, DO NOT CAUSE HAMA, AND ARE A VIABLE MINIMALLY TOXIC ALTERNATIVE IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA (NHL)
Authors: DAVIS T LEVY R WHITE CA MALONEY DG LINK B VELASQUEZ WS VARNS C GARDNER C GRILLOLOPEZ AJ
Citation: T. Davis et al., RETREATMENTS WITH RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) HAVE SIGNIFICANTEFFICACY, DO NOT CAUSE HAMA, AND ARE A VIABLE MINIMALLY TOXIC ALTERNATIVE IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 2269-2269
ACUTE MYELOFIBROSIS TERMINATING IN ACUTE LYMPHOBLASTIC-LEUKEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: DUNPHY CH KITCHEN S SARAVIA O VELASQUEZ WS
Citation: Ch. Dunphy et al., ACUTE MYELOFIBROSIS TERMINATING IN ACUTE LYMPHOBLASTIC-LEUKEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE, American journal of hematology, 51(1), 1996, pp. 85-89
ANTIFUNGAL EFFECTS OF YEAST-DERIVED RHU-GM-CSF IN PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY GIVEN WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANTATION - A RETROSPECTIVE ANALYSIS
Authors: PETERS BG ADKINS DR HARRISON BR VELASQUEZ WS DUNPHY FR PETRUSKA PJ BOWERS CE NIEMEYER R MCINTYRE W VRAHNOS D AUBERRY SE SPITZER G
Citation: Bg. Peters et al., ANTIFUNGAL EFFECTS OF YEAST-DERIVED RHU-GM-CSF IN PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY GIVEN WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANTATION - A RETROSPECTIVE ANALYSIS, Bone marrow transplantation, 18(1), 1996, pp. 93-102
MULTIPLE-MYELOMA WITH MONOCLONAL SURFACE-IMMUNOGLOBULIN EXPRESSION - A CASE-REPORT
Authors: DUNPHY CH GALINDO LM VELASQUEZ WS
Citation: Ch. Dunphy et al., MULTIPLE-MYELOMA WITH MONOCLONAL SURFACE-IMMUNOGLOBULIN EXPRESSION - A CASE-REPORT, Acta cytologica, 40(2), 1996, pp. 358-362
PEGASPARGASE VERSUS ASPARAGINASE IN ADULT ALL - A PHARMACOECONOMIC ASSESSMENT
Authors: PETERS BG GOECKNER BJ PONZILLO JJ VELASQUEZ WS WILSON AL
Citation: Bg. Peters et al., PEGASPARGASE VERSUS ASPARAGINASE IN ADULT ALL - A PHARMACOECONOMIC ASSESSMENT, Formulary, 30(7), 1995, pp. 388-393
RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE
Authors: SUKI S SWAN F TUCKER S FRITSCHE HA REDMAN JR RODRIGUEZ MA MCLAUGHLIN P ROMAGUERA J HAGEMEISTER FB VELASQUEZ WS SARRIS AH YOUNES A CABANILLAS F
Citation: S. Suki et al., RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE, Leukemia & lymphoma, 18(1-2), 1995, pp. 87-92
SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION
Authors: FULLER LM KRASIN MJ VELASQUEZ WS ALLEN PK MCLAUGHLIN P RODRIGUEZ MA HAGEMEISTER FB SWAN F CABANILLAS F PALMER JL COX JD
Citation: Lm. Fuller et al., SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 3-11
NATURAL-KILLER-CELL LYMPHOPROLIFERATIVE DISORDER OF GRANULAR LYMPHOCYTES PRESENTING AS HEMOLYTIC-ANEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: DUNPHY CH VELASQUEZ WS MORRIS RW SMITH J
Citation: Ch. Dunphy et al., NATURAL-KILLER-CELL LYMPHOPROLIFERATIVE DISORDER OF GRANULAR LYMPHOCYTES PRESENTING AS HEMOLYTIC-ANEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE, Clinical immunology and immunopathology, 76(1), 1995, pp. 37-43
ASHAP+ -ABMT - AN EFFECTIVE STRATEGY FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD)/
Authors: VELASQUEZ WS PEREIRA AR DUNPHY F BROUN GO PETRUSKA PJ BROUN ER
Citation: Ws. Velasquez et al., ASHAP+ -ABMT - AN EFFECTIVE STRATEGY FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD)/, Blood, 86(10), 1995, pp. 3289-3289
ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY
Authors: VELASQUEZ WS MCLAUGHLIN P TUCKER S HAGEMEISTER FB SWAN F RODRIGUEZ MA ROMAGUERA J RUBENSTEIN E CABANILLAS F
Citation: Ws. Velasquez et al., ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY, Journal of clinical oncology, 12(6), 1994, pp. 1169-1176
RANDOMIZED STUDY OF GROWTH-FACTORS POST-PERIPHERAL-BLOOD STEM-CELL TRANSPLANT - NEUTROPHIL RECOVERY IS IMPROVED MODEST CLINICAL BENEFIT
Authors: SPITZER G ADKINS DR SPENCER V DUNPHY FR PETRUSKA PJ VELASQUEZ WS BOWERS CE KRONMUELLER N NIEMEYER R MCINTYRE W
Citation: G. Spitzer et al., RANDOMIZED STUDY OF GROWTH-FACTORS POST-PERIPHERAL-BLOOD STEM-CELL TRANSPLANT - NEUTROPHIL RECOVERY IS IMPROVED MODEST CLINICAL BENEFIT, Journal of clinical oncology, 12(4), 1994, pp. 661-670
ESHAP CHEMOTHERAPY FOR RELAPSED REFRACTORY NON-HODGKINS-LYMPHOMA - REPLY
Authors: VELASQUEZ WS
Citation: Ws. Velasquez, ESHAP CHEMOTHERAPY FOR RELAPSED REFRACTORY NON-HODGKINS-LYMPHOMA - REPLY, Journal of clinical oncology, 12(12), 1994, pp. 2766-2766
PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA
Authors: VELASQUEZ WS
Citation: Ws. Velasquez, PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA, Journal of neuro-oncology, 20(2), 1994, pp. 177-185
INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS
Authors: VELASQUEZ WS MCLAUGHLIN P FULLER LM ALLEN PK TUCKER SL SWAN F RODRIGUEZ MA HAGEMEISTER FB CABANILLAS FF
Citation: Ws. Velasquez et al., INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS, Cancer, 73(9), 1994, pp. 2408-2416
ASHAP, AN EFFECTIVE TREATMENT FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)
Authors: VELASQUEZ WS DUNPHY F SANTILLANA S ADKINS D BOWERS C BROUN GO PETRUSKA PJ SPITZER G
Citation: Ws. Velasquez et al., ASHAP, AN EFFECTIVE TREATMENT FOR RELAPSING AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000138-10000138
TANDEM HIGH-DOSE CHEMOTHERAPY REGIMENS IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH RELAPSING OF REFRACTORY HODGKINS (HD) AND NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY-REPORT
Authors: VELASQUEZ WS DUNPHY F SANTILLANA S ADKINS D BOWERS C BROUN GO PETRUSKA PJ SPITZER G
Citation: Ws. Velasquez et al., TANDEM HIGH-DOSE CHEMOTHERAPY REGIMENS IMPROVE DISEASE-FREE SURVIVAL IN PATIENTS WITH RELAPSING OF REFRACTORY HODGKINS (HD) AND NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY-REPORT, Blood, 82(10), 1993, pp. 10000138-10000138
THERAPY OF RELAPSED OR REFRACTORY LOW-GRADE FOLLICULAR LYMPHOMAS - FACTORS ASSOCIATED WITH COMPLETE REMISSION, SURVIVAL AND TIME TO TREATMENT FAILURE
Authors: SPINOLO JA CABANILLAS F DIXON DO KHORANA SM MCLAUGHLIN P VELASQUEZ WS HAGEMEISTER FB REDMAN JR SWAN F
Citation: Ja. Spinolo et al., THERAPY OF RELAPSED OR REFRACTORY LOW-GRADE FOLLICULAR LYMPHOMAS - FACTORS ASSOCIATED WITH COMPLETE REMISSION, SURVIVAL AND TIME TO TREATMENT FAILURE, Annals of oncology, 3(3), 1992, pp. 227-232
Risultati: 1-18 |